| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 604.815 | 624.582 | 635.663 | 575.832 | 625.559 | 620.576 | 664.848 | 756.056 | 753.179 | 779.846 |
| Total Income - EUR | 617.758 | 636.374 | 644.858 | 588.538 | 651.195 | 639.687 | 684.627 | 768.562 | 851.295 | 809.116 |
| Total Expenses - EUR | 561.806 | 551.413 | 583.784 | 569.138 | 622.399 | 615.247 | 663.312 | 739.860 | 760.747 | 799.613 |
| Gross Profit/Loss - EUR | 55.953 | 84.961 | 61.074 | 19.400 | 28.796 | 24.441 | 21.315 | 28.702 | 90.548 | 9.504 |
| Net Profit/Loss - EUR | 44.709 | 70.774 | 51.212 | 13.483 | 22.244 | 18.832 | 15.135 | 21.407 | 82.721 | 4.322 |
| Employees | 7 | 7 | 5 | 6 | 6 | 6 | 8 | 6 | 5 | 5 |
Check the financial reports for the company - Alcpharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 50.357 | 52.343 | 54.690 | 54.087 | 54.145 | 79.706 | 69.816 | 63.185 | 91.506 | 44.963 |
| Current Assets | 158.531 | 176.832 | 185.738 | 176.222 | 185.268 | 181.518 | 192.691 | 232.420 | 190.361 | 151.869 |
| Inventories | 42.560 | 49.161 | 48.505 | 39.018 | 54.776 | 56.502 | 54.958 | 73.278 | 56.503 | 40.681 |
| Receivables | 52.870 | 41.444 | 80.668 | 64.165 | 63.356 | 72.604 | 68.334 | 83.473 | 66.315 | 62.353 |
| Cash | 63.101 | 86.227 | 56.566 | 73.038 | 67.136 | 52.412 | 69.399 | 75.669 | 67.543 | 48.835 |
| Shareholders Funds | 187.054 | 74.516 | 54.891 | 67.367 | 23.912 | 20.468 | 35.149 | 23.012 | 85.495 | 69.237 |
| Social Capital | 157 | 156 | 153 | 150 | 148 | 145 | 142 | 142 | 142 | 141 |
| Debts | 21.834 | 154.659 | 185.538 | 162.943 | 215.501 | 240.756 | 227.358 | 272.593 | 198.279 | 132.280 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Alcpharma Srl